Respiratory syncytial virus (RSV) is a rising public health issue across all age groups. With new vaccines and monoclonal antibodies now available, pharmacists need to stay ahead of the rapidly evolving practice recommendations.
This session unpacks the latest on RSV prevention: Who’s most at risk, What products are available, and When each should be given. Learn how to identify eligible patients, provide evidence-based recommendations, and confidently integrate RSV protection into everyday pharmacy practice; from newborns to older adults!
Learning objectives:
- Identify populations at risk of RSV and current prevention strategies available in Australia.
- Discuss vaccine and monoclonal antibody options, including indications, timing, and co-administration.
- Recognise the pharmacist’s role in supporting RSV prevention and patient education across all age groups.
Competency standards (2016): 3.1, 3.5, 3.6
